SEC Rule 2a-5

Overview and Regulatory Purpose

The accurate determination of net asset value is foundational to the entire registered investment company regulatory framework. Every investor transaction in an open-end fund — every purchase and every redemption — occurs at the fund's NAV per share, calculated as the fund's total assets minus its total liabilities divided by the number of outstanding shares. For securities with readily available market quotations — exchange-listed equitys, actively traded government bonds, and other instruments for which a current market price can be immediately determined — NAV calculation is straightforward, since Section 2(a)(41)(B) of the Investment Company Act directs that such securities be valued at current market value. 

For securities without readily available market quotations — illiquid bonds, private credit, private equity holdings, structured products, loan participations, thinly traded securities, and the full range of alternative assets that registered funds increasingly hold — Section 2(a)(41)(B) directs that such securities be valued at fair value as determined in good faith by the fund's board of directors.

This board-level fair value determination obligation has been a feature of the Investment Company Act since its 1940 adoption, reflecting Congress's determination that the valuation of illiquid or hard-to-value assets requires human judgment applied in good faith rather than mechanical application of market prices that do not exist for those assets. 

The challenge that Rule 2a-5 addresses is that by 2020, this historical framework had become functionally misaligned with how fund governance actually operates. The prior guidance — embodied in ASR 113 (1969) and ASR 118 (1970) — had been interpreted to mean that the board itself must make each fair value determination, creating compliance structures in which boards were nominally responsible for valuation decisions that were in practice entirely delegated to fund advisers and pricing service providers. 

This mismatch between formal responsibility and practical reality created governance gaps — boards that approved fair value determinations without the information, resources, or expertise to genuinely evaluate them — and compliance uncertainty for funds that needed to efficiently process high volumes of fair value determinations in a daily NAV calculation environment.

Rule 2a-5 resolves these problems by formalising the delegation of fair value determinations to the fund's investment adviser as the valuation designee, subject to a governance framework that gives the board's oversight real substance through prescribed reporting obligations, conflict of interest management requirements, and active engagement standards that prevent the delegation from becoming a rubber stamp of the adviser's own valuations.

Statutory Authority and Rulemaking History

Rule 2a-5 derives its statutory authority from Sections 2(a)(41), 38(a), and 31(a) of the Investment Company Act of 1940. Section 2(a)(41) provides the foundational definition of value that requires fair value determination in good faith by the board for investments without readily available market quotations. 

Section 38(a) provides the Commission's general rulemaking authority to make, amend, and rescind rules and regulations necessary or appropriate to carry out the Act's provisions. Section 31(a) provides authority governing the recordkeeping requirements that the companion Rule 31a-4 implements.

The Commission first proposed Rule 2a-5 in April 2020 — Investment Company Act Release No. IC-33845 — following years of examination findings, market developments, and academic and industry recognition that the valuation guidance embodied in ASR 113 and ASR 118 was outdated and that fund valuation practices had evolved substantially beyond what those releases contemplated. 

The Commission received extensive comment on the proposal and adopted the final rule on December 3, 2020 — Investment Company Act Release No. IC-34128. The final rule diverged from the proposal in two significant respects: the explicit prohibition on sub-advisers serving as valuation designees, which was not in the proposal, and the separation of the recordkeeping requirements into a standalone companion Rule 31a-4, which the adopting release confirmed would not create an automatic inference that valuation determinations were not made in good faith merely because required records were not maintained.

Rule 2a-5 became effective March 8, 2021, with a compliance date of September 8, 2022 — an eighteen-month transition period that gave funds and their advisers sufficient time to design and implement the valuation governance frameworks, reporting structures, and methodology testing processes the rule requires. No changes have been made to Rule 2a-5's operative text up to the present time.

Key Provisions and Operative Requirements

Rule 2a-5(a) establishes the four functions that must be performed to determine fair value in good faith for purposes of the Investment Company Act. These four functions define the substantive content of a good faith fair value determination — they are not merely procedural requirements but substantive analytical obligations whose performance constitutes the determination itself.

The first function is periodic assessment and management of valuation risks. The board or valuation designee must periodically assess any material risks associated with the determination of fair value of fund investments — described in the rule as valuation risks — including material conflicts of interest, and must manage those identified risks. 

Valuation risks encompass the full range of ways in which the fair value determination process might fail to produce accurate values: methodology limitations, data quality deficiencies, conflicts of interest affecting the objectivity of valuations, pricing service reliability concerns, and market liquidity conditions affecting the observability of valuation inputs. 

The rule does not prescribe the frequency of the assessment — the periodic standard is calibrated to the materiality and pace of change in the relevant risks — but the assessment must be genuinely substantive rather than perfunctory, addressing the specific valuation risks presented by the fund's actual portfolio composition and investment practices.

The second function is establishing and applying fair value methodologies. The board or valuation designee must establish methodologies that are appropriate for the specific investment types held by the fund — capturing the concept that a single valuation methodology cannot be universally applied across the full range of assets that registered funds may hold. 

Different asset types present different valuation challenges: a private credit instrument requires different inputs and analytical approaches than a thinly traded emerging market equity, and both differ from a structured product whose value depends on a complex cash flow model applied to uncertain underlying asset performance. 

The rule requires that fair value methodologies be calibrated to the specific nature of each asset type, applied consistently over time, and capable of producing valuations that represent what the fund could reasonably receive for the investment in an arm's-length transaction.

Significantly, Rule 2a-5(a)(2) specifically requires that the board or valuation designee consider, as relevant, the following factors in establishing fair value methodologies: the asset's structure, terms, and characteristics, including rights and obligations of the parties; the price of the asset and subsequent market movements in relevant markets or for comparable securities; publicly available information regarding the asset; quotations from dealers, pricing services, or other sources; and information from the issuer or counterparty. 

This non-exhaustive list of relevant considerations directly incorporates the analytical framework that sophisticated valuation practitioners apply in determining fair value for illiquid and hard-to-value assets, giving regulatory foundation to practices that were previously governed only by informal guidance.

The third function is testing fair value methodologies for appropriateness and accuracy. The board or valuation designee must periodically test the fair value methodologies to assess whether those methodologies are producing accurate valuations. 

Testing may include back-testing — comparing subsequent price discovery events such as sales, IPOs, or market transactions against the prior fair value determinations — and comparative analysis against independent third-party valuations or contemporaneous market transactions for similar assets. 

The testing function ensures that fair value methodologies remain fit for purpose over time and that systematic biases or errors in the valuation process are identified and corrected rather than perpetuated.

The fourth function is overseeing and evaluating pricing services. The board or valuation designee must establish and implement processes for the oversight and evaluation of pricing services — third-party vendors that provide pricing data for securities and other instruments held by registered funds. 

Pricing services are a primary source of fair value inputs for many categories of fund investment — fixed income securities, structured products, foreign securities, and various alternative instruments are routinely priced using data from Bloomberg, ICE Data Services, Refinitiv, and similar providers. The rule requires that the oversight process address the appropriateness and accuracy of pricing service methodologies, the quality and reliability of pricing service data, and the procedures for challenging and overriding pricing service data when the board or valuation designee believes those data do not reflect fair value.

Rule 2a-5(b) establishes the complete governance framework for board delegation of fair value determinations to a valuation designee. The valuation designee — which must be the fund's investment adviser, or for internally managed funds an officer or officers of the fund; sub-advisers are explicitly excluded from eligibility — may perform all of the fair value functions of Rule 2a-5(a), subject to the board's ongoing oversight and the specific reporting and responsibility conditions of Rule 2a-5(b).

The board oversight obligation is active rather than passive. The rule requires that the board scrutinise the information received from the valuation designee, ask probing questions about fair value methodologies and valuation results, review the designee's resources including personnel and technology infrastructure, and identify and manage conflicts of interest of the designee in the valuation process. 

The oversight obligation is not satisfied by simply receiving reports and asking no questions — the board must engage substantively with the valuation governance process in a manner that ensures the delegation to the adviser does not become a complete abdication of responsibility.

The reporting framework consists of three layers: quarterly periodic reports, annual assessments, and prompt notification of material matters. Quarterly reports must include any materials requested by the board related to fair value determinations, a summary of material fair value matters in the prior quarter including material changes in valuation risk assessments, material changes to fair value methodologies, and material changes to pricing service oversight processes. Annual reports must include an assessment of the adequacy and effectiveness of the valuation process, a summary of methodology testing results, and an assessment of resources allocated to fair value determinations. 

Material matters — defined as significant deficiencies or material weaknesses in the fair value determination process or material errors in NAV calculations — must be reported to the board within five business days of the valuation designee becoming aware of them, with follow-on reporting as the board determines appropriate.

The responsibility specification requirement directs the valuation designee to identify by title the persons responsible for fair value determinations, specify the particular functions each is responsible for, and reasonably segregate fair value determinations from portfolio management — the separation that prevents portfolio managers from unduly influencing the valuations of positions they themselves manage, a conflict of interest concern that the prior informal valuation framework had not systematically addressed.

Rule 2a-5(c) establishes the operative definition of readily available market quotations for purposes of the Investment Company Act's valuation framework. A market quotation is readily available only when it is a quoted price, unadjusted, in an active market for identical investments that the fund can access at the measurement date. This definition directly corresponds to Level 1 inputs under ASC Topic 820's fair value hierarchy — the highest-quality, most observable valuation inputs — and specifically excludes adjusted market prices, prices from inactive markets, and prices for similar but not identical instruments. 

The practical consequence of this narrow definition is that a greater universe of securities requires fair value determination under Rule 2a-5(a)'s good faith framework than under the prior, more expansive interpretation of readily available market quotations. A lightly traded municipal bond for which a broker-dealer has provided a quote but for which no active market exists does not have a readily available market quotation under Rule 2a-5(c)'s definition, and must therefore be fair valued rather than marked to the broker-dealer quote.

Companion Rule 31a-4, adopted simultaneously with Rule 2a-5, requires funds and their advisers to maintain documentation supporting fair value determinations — including records of the information considered in reaching each determination, the methodologies applied, the testing conducted, and the pricing service oversight activities performed — for six years, the first two in an easily accessible place.

Scope of Application

Rule 2a-5 applies to all registered investment companies subject to the Investment Company Act and to business development companies that have elected treatment as registered closed-end investment companies under Section 54(a) of the Act. This scope encompasses the complete universe of registered funds — open-end mutual funds, Exchange-Traded Funds whose portfolios may include illiquid or hard-to-value instruments alongside the exchange-listed securities that form the basis for their daily portfolio transparency disclosures under Rule 6c-11, closed-end funds that may invest extensively in private credit, infrastructure, and other illiquid asset classes, money market funds governed by Rule 2a-7 whose portfolio quality standards substantially limit fair value determination occasions, and unit investment trusts whose absence of boards or advisers requires the trustee or depositor to perform the fair value functions.

For unit investment trusts specifically, the rule provides modified application: the trustee or depositor must carry out the fair value determination functions, and where an initial deposit of portfolio securities occurred before the rule's effective date and an entity other than the trustee or depositor had been designated to carry out fair value determinations, that entity may continue to perform those functions under the rule's framework.

Relationship to Related Rules and Regulations

Rule 2a-5's fair value determination framework is directly connected to Rule 22c-1's forward pricing requirement, which requires that open-end registered investment company shares be sold and redeemed at the next calculated NAV. 

The accuracy of the NAV that Rule 22c-1 requires to be used for every fund transaction depends entirely on the accuracy of the fair value determinations that Rule 2a-5 governs — a fund whose fair value determinations systematically misstate the value of illiquid portfolio holdings will produce NAVs that misinform both purchasing and redeeming shareholders, creating wealth transfers between fund shareholders that Rule 22c-1's forward pricing protection is specifically designed to prevent.

Rule 38a-1's compliance programme framework, which this dictionary has already addressed, directly incorporates Rule 2a-5 compliance as a required component of every registered fund's compliance programme. 

A fund whose Rule 38a-1 compliance programme does not specifically address the adequacy of its Rule 2a-5 valuation governance framework — including the valuation designee's methodology testing, pricing service oversight, and reporting processes — has a compliance programme that is inadequate under Rule 38a-1's reasonably designed standard. 

The interaction between Rule 2a-5 and Rule 38a-1 establishes fair value governance as a first-order compliance concern for registered fund boards and their chief compliance officers.

Rule 2a-5's definition of readily available market quotations — requiring a Level 1 input in an active market for identical instruments — directly affects the scope of cross-trading transactions permissible under Rule 17a-7, which allows affiliated registered funds to cross trade portfolio securities provided those securities have readily available market quotations. 

Under Rule 2a-5's narrow definition, securities that might previously have been treated as having readily available quotations based on broker-dealer quotes or indicative prices may no longer qualify, limiting the universe of securities eligible for cross-trading under Rule 17a-7 relative to the prior, broader interpretation.

Rule 2a-5's fair value governance framework complements the ETF-specific requirements of Rule 6c-11, which requires ETFs to publish daily portfolio holdings before NAV calculation. For ETFs holding illiquid or hard-to-value securities — a category that includes actively managed ETFs investing in private credit, bank loans, and similar instruments — the fair value determinations required under Rule 2a-5 directly inform the portfolio holdings publication that Rule 6c-11 requires, since the published holdings must reflect the valuations that the fund's Rule 2a-5 process has produced.

Amendment History and Regulatory Evolution

Rule 2a-5 has not been amended since its December 2020 adoption — no changes have been made to the rule's operative text up to the present time. The rule's compliance date of September 2022 completed the transition from the prior valuation guidance regime — which was formally rescinded upon the compliance date — to the rule-based framework, eliminating the accumulated body of ASR releases, no-action letters, and staff guidance that had previously governed fund valuation practices.

The most significant post-adoption development in the Rule 2a-5 landscape has been the Office of Examinations' examination programme assessing fund compliance with the rule's requirements — including the adequacy of valuation risk assessments, the robustness of fair value methodology testing, the quality of pricing service oversight programmes, and the effectiveness of the reporting framework through which valuation designees discharge their obligations to fund boards. 

The Division of Investment Management's ongoing engagement with valuation governance questions through staff guidance and no-action letter practice continues to refine the practical application of the rule's principles-based framework to specific asset types and market circumstances.

Enforcement Context and SEC Action Patterns

Rule 2a-5 enforcement arises in the context of fund NAV calculation failures — cases where inadequate fair value determination processes produce NAVs that materially misstate the fund's per-share value, resulting in wealth transfers between purchasing and redeeming shareholders and potentially triggering restatement obligations. 

The Commission has addressed fair value governance failures in enforcement actions characterised by the same deficiencies that Rule 2a-5 was specifically adopted to prevent: advisers that controlled the fair value determination process without meaningful board oversight, methodologies that were applied inconsistently or without documented justification, pricing service data accepted without adequate challenge or testing, and conflicts of interest in the valuation process that were not identified, disclosed, or managed.

The Office of Examinations' risk alert framework has identified specific Rule 2a-5 examination priorities, including the adequacy of valuation designee reporting to fund boards, the specificity and robustness of fair value methodology documentation, and the procedures for challenging and overriding pricing service data when those data appear stale, unreliable, or inconsistent with other available market information.

Examination Relevance and Key Takeaways

Rule 2a-5 is examined at the Series 65 level in the context of registered investment company governance and the board's obligations with respect to portfolio valuation. 

The four functions required for good faith fair value determination — valuation risk assessment, methodology establishment and application, methodology testing, and pricing service oversight — are the primary substantive examination content. 

The valuation designee structure — permitting the board to delegate fair value determinations to the investment adviser subject to the oversight, reporting, and responsibility specification conditions — and the explicit exclusion of sub-advisers from eligibility as valuation designees are consistently examined governance distinctions.

The narrow definition of readily available market quotations under Rule 2a-5(c) — limited to Level 1 inputs in active markets for identical instruments, explicitly excluding adjusted prices and prices for similar but not identical assets — is examined as the threshold concept determining when fair value determination is required as opposed to mark-to-market pricing.

The key points to retain are these. Rule 2a-5 establishes the framework for good faith fair value determination of registered fund investments under Section 2(a)(41) of the Investment Company Act. Good faith determination requires four functions: periodic assessment and management of valuation risks including conflicts of interest; establishment and application of appropriate fair value methodologies; testing of methodologies for appropriateness and accuracy; and oversight and evaluation of pricing services. 

The board may designate the fund's investment adviser — but not a sub-adviser — as valuation designee to perform these functions, subject to quarterly and annual reporting to the board, prompt notification within five business days of material matters, specification of responsible persons with segregation from portfolio management, and active board oversight of the designee's performance. 

A market quotation is readily available only when it is a Level 1 input — a quoted price, unadjusted, in an active market for identical instruments accessible at the measurement date. Companion Rule 31a-4 requires six-year retention of fair value determination documentation. 

Rule 2a-5 applies to all registered investment companies and BDCs, with modified application for unit investment trusts. Rule 2a-5 was adopted December 3, 2020, became effective March 8, 2021, with compliance required from September 8, 2022. No changes have been made to the rule's operative text up to the present time.